KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is reviewing information about a medication that has
completed phase III clinical trials. Which statement best
describes the primary purpose of this phase of drug
development?
A. To determine the medication's molecular structure in the
laboratory
B. To evaluate safety and effectiveness in a large population
before regulatory review
C. To monitor rare adverse effects after widespread marketing
D. To study the medication only in healthy volunteers
Correct Answer: B
Rationale:
Phase III clinical trials involve large groups of participants with
the target condition to confirm therapeutic effectiveness,
identify common adverse effects, compare treatments when
appropriate, and provide data for regulatory review. Option A
describes preclinical research rather than clinical trials. Option C
refers to post-marketing (phase IV) surveillance. Option D is
more characteristic of early phase I studies, which primarily
assess safety and dosage in a small number of participants.
Question 2
,A patient asks why a newly prescribed medication cannot be
approved after laboratory testing alone. Which response by the
nurse is most appropriate?
A. "Laboratory testing is sufficient because medications behave
the same in humans."
B. "Clinical studies help determine how a medication performs
in people, including its safety and effectiveness."
C. "Human testing is performed only to establish the
medication's color and formulation."
D. "Clinical trials are optional once animal studies are
completed."
Correct Answer: B
Rationale:
Clinical trials are necessary because laboratory and animal
studies cannot fully predict how medications will affect
humans. Human studies provide information about safety,
effectiveness, dosing, and adverse effects. Option A is incorrect
because human responses differ from laboratory models.
Option C is inaccurate because clinical trials evaluate
therapeutic outcomes, not formulation characteristics. Option D
is incorrect because regulatory approval generally requires
adequate clinical evidence.
Question 3
, A nurse is teaching a patient about generic medications. Which
statement by the patient indicates correct understanding?
A. "Generic medications must demonstrate comparable quality
and therapeutic performance to the brand-name product."
B. "Generic medications always contain different active
ingredients."
C. "Generic medications are less effective because they cost
less."
D. "Generic medications never require regulatory review."
Correct Answer: A
Rationale:
Approved generic medications contain the same active
ingredient, strength, dosage form, and route of administration
as the reference product and must meet appropriate quality
and bioequivalence standards. Option B is incorrect because the
active ingredient is the same. Option C incorrectly equates
lower cost with lower effectiveness. Option D is incorrect
because generic medications undergo regulatory review before
approval.
Question 4
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is reviewing information about a medication that has
completed phase III clinical trials. Which statement best
describes the primary purpose of this phase of drug
development?
A. To determine the medication's molecular structure in the
laboratory
B. To evaluate safety and effectiveness in a large population
before regulatory review
C. To monitor rare adverse effects after widespread marketing
D. To study the medication only in healthy volunteers
Correct Answer: B
Rationale:
Phase III clinical trials involve large groups of participants with
the target condition to confirm therapeutic effectiveness,
identify common adverse effects, compare treatments when
appropriate, and provide data for regulatory review. Option A
describes preclinical research rather than clinical trials. Option C
refers to post-marketing (phase IV) surveillance. Option D is
more characteristic of early phase I studies, which primarily
assess safety and dosage in a small number of participants.
Question 2
,A patient asks why a newly prescribed medication cannot be
approved after laboratory testing alone. Which response by the
nurse is most appropriate?
A. "Laboratory testing is sufficient because medications behave
the same in humans."
B. "Clinical studies help determine how a medication performs
in people, including its safety and effectiveness."
C. "Human testing is performed only to establish the
medication's color and formulation."
D. "Clinical trials are optional once animal studies are
completed."
Correct Answer: B
Rationale:
Clinical trials are necessary because laboratory and animal
studies cannot fully predict how medications will affect
humans. Human studies provide information about safety,
effectiveness, dosing, and adverse effects. Option A is incorrect
because human responses differ from laboratory models.
Option C is inaccurate because clinical trials evaluate
therapeutic outcomes, not formulation characteristics. Option D
is incorrect because regulatory approval generally requires
adequate clinical evidence.
Question 3
, A nurse is teaching a patient about generic medications. Which
statement by the patient indicates correct understanding?
A. "Generic medications must demonstrate comparable quality
and therapeutic performance to the brand-name product."
B. "Generic medications always contain different active
ingredients."
C. "Generic medications are less effective because they cost
less."
D. "Generic medications never require regulatory review."
Correct Answer: A
Rationale:
Approved generic medications contain the same active
ingredient, strength, dosage form, and route of administration
as the reference product and must meet appropriate quality
and bioequivalence standards. Option B is incorrect because the
active ingredient is the same. Option C incorrectly equates
lower cost with lower effectiveness. Option D is incorrect
because generic medications undergo regulatory review before
approval.
Question 4
